Theravance Biopharma Inc (TBPH)
R&D Expenses
$25.62M
TTM · Period ending: · USD
TBPH R&D Expenses
Latest reported$25.62Mperiod ending
Latest reported$25.62Mperiod ending
TBPH R&D Expenses ($98.85M → $25.62M)
Annual R&D Expenses
High-resolution chart · PNG
TBPH r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 37,414,000 | |
| 38,050,000 | |
| 46,344,000 | |
| 70,074,000 | |
| 201,548,000 | |
| 260,953,000 | |
| 219,248,000 | |
| 201,348,000 | |
| 173,887,000 | |
| 141,712,000 | |
| 129,165,000 | |
| 168,522,000 | |
| 120,579,000 | |
| 113,995,000 | |
| 98,850,000 |